Bone Biologics Corp (11)

Browse by Contract Category

Contracts

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 15, 2021)
Amendment dated November 7, 2020 to the following Convertible Promissory Notes: (a) Note dated October 24, 2014, as amended, in the principal amount of 5,000,000; (b) Note dated... (Filed With SEC on April 15, 2021)
First Amendment to the Amended and Restated License Agreement dated August 13, 2020 between the Company and the Regents of the University of California (Filed With SEC on April 15, 2021)
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 30, 2020)
Amendment dated November 7, 2019 to the following Convertible Promissory Notes: (a) Note dated October 24, 2014, as amended, in the principal amount of 000,000; (b) Note dated May... (Filed With SEC on March 30, 2020)
Amendment dated November 7, 2019 to the following Convertible Promissory Notes: (a) Note dated October 24, 2014, as amended, in the principal amount of 000,000; (b) Note dated May... (Filed With SEC on November 14, 2019)
Note Purchase Agreement dated September 19, 2019 (Filed With SEC on September 25, 2019)
Convertible Secured Term Note dated September 19, 2019 (Filed With SEC on September 25, 2019)
Independent Contractor Agreement dated as of June 28, 2019 between the Company and Stephen LaNeve (Filed With SEC on June 28, 2019)
Independent Contractor Agreement dated as of June 28, 2019 between the Company and Deina Walsh (Filed With SEC on June 28, 2019)
Amended and Restated Exclusive License Agreement, dated as of March 21, 2019, by and between the Company and The Regents of the University of California (Filed With SEC on April 16, 2019)